Are probiotics a feasible intervention for prevention of diarrhoea in the developing world?
- PMID: 20799986
- PMCID: PMC2940794
- DOI: 10.1186/1757-4749-2-10
Are probiotics a feasible intervention for prevention of diarrhoea in the developing world?
Abstract
With more than 1.4 million of the 9 million child deaths being attributed to diarrhoea in 2008 and 49% of them occurring in five countries namely, India, Nigeria, Democratic Republic of the Congo, Pakistan and China, there is an urgent need for intervention to prevent and control diarrhoeal diseases. Of the various interventions, probiotics offer immense potential. The past decade has witnessed the validation of their utility for the prevention, treatment and management of a variety of infective and non infective disorders. The most investigated field continues to remain infectious diarrhoea and compelling evidence comes from randomized placebo controlled trials. While results from these studies are encouraging most of them reflect the outcomes of the developed world. Developing countries like India continue to struggle with nutritional and health challenges and bear the greatest burden of diarrhoea. A paucity of data from the developing countries limits the definite recommendation of probiotics. In these countries curd, often confused for a probiotic, is practiced as an integral part of the culture. While the nutritional benefits of these products cannot be understated, it is still uncertain whether these products can be classified as a probiotic. The emergence of probiotic foods which are scientifically validated for their efficacy and impart defined health benefits offer an excellent opportunity to improve public health. A recent randomized controlled trial conducted by the National Institute of Cholera and Enteric Diseases in Kolkata, India demonstrated a protective efficacy of 14% in preventing diarrhoea among children who received a probiotic. For the developing world however the vision for probiotics would mean a fundamental change in perception and developing a well planned strategy to allow interventions like probiotics to permeate to impoverished settings, where the assault of micro organisms is on a daily basis. This would mean that probiotics are ingrained into the public health system without being seen as a medicine.
Similar articles
-
Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slum.Epidemiol Infect. 2011 Jun;139(6):919-26. doi: 10.1017/S0950268810001780. Epub 2010 Jul 30. Epidemiol Infect. 2011. PMID: 20670468 Clinical Trial.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials.Lancet Infect Dis. 2006 Jun;6(6):374-82. doi: 10.1016/S1473-3099(06)70495-9. Lancet Infect Dis. 2006. PMID: 16728323 Review.
-
The role of nutrition in diarrhoea syndromes.Curr Opin Clin Nutr Metab Care. 2003 Sep;6(5):563-7. doi: 10.1097/00075197-200309000-00010. Curr Opin Clin Nutr Metab Care. 2003. PMID: 12913674 Review.
-
Probiotics and prebiotics to combat enteric infections and HIV in the developing world: a consensus report.Gut Microbes. 2011 May-Jun;2(3):198-207. doi: 10.4161/gmic.2.3.16106. Epub 2011 May 1. Gut Microbes. 2011. PMID: 21804356
Cited by
-
Probiotics for gastrointestinal disorders: Proposed recommendations for children of the Asia-Pacific region.World J Gastroenterol. 2017 Dec 7;23(45):7952-7964. doi: 10.3748/wjg.v23.i45.7952. World J Gastroenterol. 2017. PMID: 29259371 Free PMC article. Review.
-
Maternal Supplementation with LGG Reduces Vaccine-Specific Immune Responses in Infants at High-Risk of Developing Allergic Disease.Front Immunol. 2013 Nov 26;4:381. doi: 10.3389/fimmu.2013.00381. eCollection 2013. Front Immunol. 2013. PMID: 24324465 Free PMC article.
-
Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes.Vaccines (Basel). 2017 Dec 11;5(4):50. doi: 10.3390/vaccines5040050. Vaccines (Basel). 2017. PMID: 29232932 Free PMC article. Review.
-
Probiotics in dietary guidelines and clinical recommendations outside the European Union.World J Gastroenterol. 2014 Nov 21;20(43):16095-100. doi: 10.3748/wjg.v20.i43.16095. World J Gastroenterol. 2014. PMID: 25473160 Free PMC article. Review.
References
-
- Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C. Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national caused of child mortality in 2008: a systematic analysis. Lancet. 2010;375:1969–1987. doi: 10.1016/S0140-6736(10)60549-1. - DOI - PubMed
-
- FAO/WHO. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report. http://www.fao.org/es/ESN/Probio/probio.htm
-
- Tuohy KM, Pinart-Gilberga M, Jones M, Hoyles L, McCartney AL, Gibson GR. Survivability of a probiotic Lactobacillus casei in the gastro - intestinal tract of healthy human volunteers and its impact on the fecal microflora. J Appl Microbiol. 2007;102:1026–1032. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous